What is Aarti Pharmalabs Ltd (AARTIPHARM) share price return in the past 10 years?

Data is not available for this company

What is the share price of Aarti Pharmalabs Ltd (AARTIPHARM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Aarti Pharmalabs Ltd (AARTIPHARM) on 02-Jul-2026 16:59:59 at 16:59 is 698.75.

What is the P/E ratio of Aarti Pharmalabs?

The latest standalone P/E ratio of Aarti Pharmalabs as of 02-Jul-2026 is 35.96.

What is the P/B ratio of Aarti Pharmalabs Ltd (AARTIPHARM)?

The latest standalone P/B ratio of Aarti Pharmalabs Ltd (AARTIPHARM) as of 02-Jul-2026 is 3.20.

What is the 52-week high and low of Aarti Pharmalabs Ltd (AARTIPHARM)?

The 52-week high of Aarti Pharmalabs Ltd (AARTIPHARM) is Rs. 971.50 and the 52-week low is Rs. 583.85.

Aarti Pharmalabs Ltd (AARTIPHARM) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Aarti Pharmalabs Ltd (AARTIPHARM)
Brand: Aarti Pharmalabs

Aarti Pharmalabs Ltd (AARTIPHARM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543748 NSE: AARTIPHARM Pharmaceuticals & Drugs | Small Cap | Aarti Pharmalabs Share Price

Aarti Pharmalabs Ltd (AARTIPHARM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543748 NSE: AARTIPHARM Pharmaceuticals & Drugs | Small Cap | Aarti Pharmalabs Share Price

Key Metrics

Valuation Multiples

Market Cap

₹6,336 Cr.

Current Price

₹698.8

52-Week Low / High

₹584 / 972

TTM EPS

₹19.4

TTM Sales

₹1,798 Cr.

Book Value per Share

₹218.6

P/E Ratio

35.96

Higher than its 5-year historical median

Industry PE

49.2

Price to Book (P/B)

3.20

In line with its 5-year historical median

Price to Sales (P/S)

3.52

In line with its 5-year historical median

EV/EBITDA

18.07

Higher than its 5-year historical median

Dividend Yield

0.72%

Profitability Efficiency

Return on Equity (ROE)

14.86%

Outperforms industry median

Return on Capital Employed (ROCE)

17.61%

Outperforms industry median

Return on Assets (ROA)

10.25%

Operating Profit Margin

24.1%

Net Profit Margin

14.53%

Gross Profit Margin

23.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

17.92%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

23.22%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

28.26%

Asset Quality

Promoter Holding

43.08%

Pledged shares (%) of Promoter's holding (%)

11.03%

Reserves

₹1,937 Cr.

Equity

₹45.3 Cr.

Face Value

₹5

All Time Low / High

₹269.00 / 971.50

Aarti Pharmalabs stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is Aarti Pharmalabs Ltd a good quality company?

Aarti Pharmalabs Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Aarti Pharmalabs Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Aarti Pharmalabs Ltd vs industry peers?

Aarti Pharmalabs Ltd revenue CAGR is 23.47%, compared to the industry median CAGR of 6.81%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Aarti Pharmalabs Ltd?

Promoters hold 43.08% of the Aarti Pharmalabs Ltd, with 11.03% of their stake pledged, indicating high pledge risk.

Q.1 Stock return of Aarti Pharmalabs Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of 28.06% based on the current price.

DeciZen - make an informed investing decision on Aarti Pharmalabs

Standalone basis

1. Right Stock

10 Year X-ray Pro

Long Term Prospect

2. Right Price

Price Chart

3. Right Time ⓘ

#Likely Future 5 Year CAGR.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	0%	0%	0%	-8.1%	-1.9%	18%	15.6%	16.6%	17.6%	-
Value Creation Index ⓘ	NA	NA	NA	NA	-1.6	-1.1	0.3	0.1	0.2	0.3	-
Growth Parameters ⓘ
Sales ⓘ	0	0	0	0	0	0	941	1,511	1,502	1,771	1,798
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	60.6%	-0.6%	17.9%	-
Adj EPS ⓘ	0	0	0	0	-0.8	-0.2	4,268.2	19	22.1	28.2	19.4
YoY Gr.	-	NA	NA	NA	NA	NA	NA	-99.6%	16.6%	27.5%	-
BVPS (₹) ⓘ	0	0	0	0	9.3	9.1	49,558.5	158.7	178.9	203.3	218.6
Adj Net Profit ⓘ	0	0	0	0	-0	-0	107	172	200	255	176
Cash Flow from Ops. ⓘ	0	0	0	0	-0	0	-64.8	216	184	340	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	-5	1	1.4	1.2	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	23.5%	17.9%
Adj EPS ⓘ	NA	NA	-81.2%	27.5%
BVPSⓘ	NA	85.5%	-84%	13.6%
Share Price	-	-	24%	-22.7%

Key Financial Parameters ⓘ

	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-8.1	-2	16.6	12.6	13.1	14.7	9.2
Op. Profit Mgn % ⓘ	0	0	19.1	20.4	23	24.1	22.6
Net Profit Mgn % ⓘ	0	0	11.3	11.4	13.3	14.4	9.8
Debt to Equity ⓘ	0	0.1	0.3	0.1	0.2	0.2	0.1
Working Cap Days ⓘ	0	0	163	219	256	245	124
Cash Conv. Cycle ⓘ	0	0	116	150	166	150	46

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	941	1,511	1,502	1,771
Operating Expenses ⓘ +	0	0	761	1,203	1,156	1,345
Manufacturing Costs	0	0	202	170	181	213
Material Costs	0	0	452	818	752	879
Employee Cost	0	0	80	114	120	140
Other Costs ⓘ	0	0	27	101	103	112
Operating Profit ⓘ	-0	-0	180	308	346	427
Operating Profit Margin (%)	-	-	19.1%	20.4%	23.0%	24.1%
Other Income ⓘ +	0	0	3	1	11	14
Exceptional Items ⓘ	0	0	0	0	0	0
Interest ⓘ	0	0	11	20	17	26
Depreciation ⓘ	0	0	37	56	66	79
Profit Before Tax ⓘ	-0	-0	134	233	275	336
Tax ⓘ	0	0	27	62	74	79
Profit After Tax	-0	-0	107	172	201	257
PAT Margin (%)	-	-	11.3%	11.4%	13.4%	14.5%
Adjusted EPS (₹)	-0.8	-0.2	4,269.1	19.0	22.1	28.4
Dividend Payout Ratio (%)	0%	0%	0%	10.60%	13.60%	17.60%

Valuation of Aarti Pharmalabs - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0	0	1,239	1,439	1,621	1,842
Share Capital ⓘ	0	0	0	45	45	45
Reserves ⓘ	-0	-0	1,239	1,393	1,576	1,797
Debt +	0	0	325	207	251	395
Long Term Debt	0	0	0	0	0	104
Short Term Debt	0	0	325	207	251	291
Minority Interest	0	0	0	0	0	0
Trade Payables	0	0	132	212	255	249
Others Liabilities ⓘ	0	0	132	119	170	238
Total Liabilities ⓘ	0	0	1,827	1,976	2,297	2,724
Fixed Assets
Net Fixed Assets ⓘ +	0	0	701	848	953	1,059
Gross Block	0	0	1,101	1,304	1,472	1,653
Accumulated Depreciation	0	0	400	455	519	594
CWIP ⓘ	0	0	187	102	137	369
Investments ⓘ	0	0	40	55	62	57
Inventories	0	0	444	538	582	544
Trade Receivables	0	0	304	372	449	553
Cash Equivalents	0	0	56	0	4	4
Others Assets ⓘ	0	0	93	61	110	138
Total Assets ⓘ	0	0	1,827	1,976	2,297	2,724

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	0	-65	216	184	340
PBT ⓘ	-0	-0	134	233	275	336
Adjustment ⓘ	0	0	46	77	81	109
Changes in Working Capital ⓘ	0	0	-230	-38	-125	-47
Tax Paid ⓘ	0	0	-15	-57	-47	-59
Cash Flow From Investing Activity ⓘ +	0	0	-134	-116	-184	-420
Capex	0	0	-136	-99	-189	-433
Net Investments	0	0	0	-18	-5	2
Others ⓘ	0	0	2	1	10	12
Cash Flow From Financing Activity ⓘ +	0	0	255	-157	4	79
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	100
Interest Paid ⓘ	0	0	-11	-20	-17	-23
Dividend Paid ⓘ	0	0	0	-18	-18	-32
Others ⓘ	0	0	266	-118	39	34
Net Cash Flow ⓘ	0	0	56	-56	4	-1

Financial Ratio

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	N/A	N/A	17.23	12.83	13.11	14.86
ROCE (%)	N/A	N/A	18.03	15.6	16.55	17.61
Asset Turnover Ratio	0	0	1.03	0.79	0.7	0.71
PAT to CFO Conversion(x)	N/A	N/A	-0.61	1.26	0.92	1.32
Working Capital Days
Receivable Days	0	0	118	81.60	99.70	103.20
Inventory Days	0	0	172.40	118.60	136.10	116.10
Payable Days	0	0	53.20	76.80	113.40	104.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

0.01

11.03

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarti Pharmalabs Ltd FAQs

The current trading price of Aarti Pharmalabs on 02-Jul-2026 16:59 is ₹698.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Aarti Pharmalabs stood at ₹6,336.3 Cr

The latest P/E ratio of Aarti Pharmalabs as of 01-Jul-2026 is 35.96.

The latest P/B ratio of Aarti Pharmalabs as of 01-Jul-2026 is 3.20.

The 52-week high of Aarti Pharmalabs is ₹971.5 and the 52-week low is ₹583.9.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarti Pharmalabs is ₹1,798 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Pharmalabs Ltd is a average quality company.

The key valuation ratios of Aarti Pharmalabs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Aarti Pharmalabs Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.

Over the past two decades, enabled by cutting-edge R&D and manufacturing capabilities APL has evolved as a reliable partner of choice for generic players and innovators across the globe. The company specialises in generic APIs, generic intermediates, and xanthine derivatives. It delivers CDMO services for drug substance/NCE development and manufacturing for innovative pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products.

With the biggest manufacturing capacity in India for its flagship product ‘Caffeine’ APL has emerged as a preferred partner for the Beverages, Nutraceuticals manufacturing companies, and Pharmaceuticals Industries across the world.

Business area of the company

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).

Products and services

API
Intermediates
CDMO Services
Caffeine
Xanthine Derivatives
Acid & Allied

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Aarti Pharmalabs Ltd (AARTIPHARM)

Aarti Pharmalabs Ltd (AARTIPHARM)

Aarti Pharmalabs stock performance

Check Before You Invest

Quality

Valuation

Price Trend

DeciZen - make an informed investing decision on Aarti Pharmalabs

1. Right Stock

2. Right Price

3. Right Time ⓘ

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Aarti Pharmalabs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarti Pharmalabs Ltd FAQs

What is the share price of Aarti Pharmalabs?

What is the market cap of Aarti Pharmalabs?

What is the P/E ratio of Aarti Pharmalabs?

What is the P/B ratio of Aarti Pharmalabs?

What is the 52-week high and low of Aarti Pharmalabs?

What is the TTM revenue of Aarti Pharmalabs?

Is Aarti Pharmalabs Ltd a good quality company?

Is Aarti Pharmalabs Ltd undervalued or overvalued?

Is Aarti Pharmalabs Ltd a good buy now?

About Aarti Pharmalabs Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.